Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AstraZeneca ( (GB:AZN) ) has issued an announcement.
AstraZeneca PLC announced that as of 31 January 2025, its issued share capital with voting rights comprises 1,550,581,134 ordinary shares. This figure is crucial for shareholders to determine their notification requirements under the UK’s Financial Conduct Authority’s Disclosure and Transparency Rules, indicating transparency in the company’s voting rights structure and facilitating shareholder engagement.
More about AstraZeneca
AstraZeneca is a global biopharmaceutical company based in Cambridge, UK, focused on the discovery, development, and commercialization of prescription medicines, particularly in the fields of Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its innovative medicines are sold in more than 125 countries, serving millions of patients worldwide.
YTD Price Performance: 8.37%
Average Trading Volume: 2,841,515
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £175.9B
See more insights into AZN stock on TipRanks’ Stock Analysis page.
